Filing Details

Accession Number:
0001209191-18-037260
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-06-12 17:00:32
Reporting Period:
2018-06-08
Accepted Time:
2018-06-12 17:00:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1492426 Horizon Pharma Plc HZNP Pharmaceutical Preparations (2834) 272179987
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1641580 K Brian Beeler C/O Horizon Pharma Plc
Connaught House, 1St Fl, 1 Burlington Rd
Dublin L2 4
Evp, General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2018-06-08 6,545 $17.00 88,418 No 4 S Direct
Ordinary Shares Disposition 2018-06-08 8,888 $18.00 79,530 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the reporting person on May 25, 2018.
  2. Includes 2,370 ordinary shares of the Issuer acquired by the reporting person on June 1, 2018 pursuant to an employee stock purchase program.